Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Fentanyl Aerosol in Chinese Cancer Patients
NCT06953453Phase 1Recruiting
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fentanyl in cancer, sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoints: Maximum Plasma Concentration at 18 hours, Time to Maximum Plasma Concentration at 18 hours and 3 more. Started Sep 2025; status: recruiting.
02
Drugs
fentanyl
03
Conditions
cancer
Beyond the preview
Go deeper on NCT06953453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06953453.